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Phospholipase D (PLD) activation by vasopressin (VP) was compared to activation by TPA in REF52 cells prelabeled with [‘HIglycerol and 
[?Y]myristic acid. Upon VP-treatment, the formation of [3H] and [‘4C]phosphatidic acid (PA) and phosphatidylethanol (PEt) was accompanied 
by the loss of radioactivity from PC and PI. However, upon TPA-treatment. radioactivity was lost from PC only. No significant changes of 
phosphatidylethanolamine and phosphatidylserme were detected in the same samples. The inclusion of 5 PM staurosporine for 10 min diminished 
the production of [‘HIPEt and [“‘C]PEt by 27% and 53% in VP-treated cells, and by 100% and 75% m TPA-treated cells, respectively. Adding 1 
mM EGTA to chelate extracellular Ca” inhibited [3H]PEt by approximately 3 1% and [14C]PEt by 17% after VP-stimulation. In contrast, EGTA 
had no effect on TPA-stimulation. The data suggest that REF52 cells contain dual PLD activities. The first is stimulated only by VP, requires Ca’+ 
and hydrolyzes PI. The second is stimulated by both TPA and VP, activated by protein kinase C and hydrolyzes PC. 
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1. INTRODUCTION 
Many agonists (hormones, neurotransmitters, 
growth factors, tumor promotors, etc.) are thought to 
elicit cell physiological responses through the action of 
phospholipase A,, C or D, which cleaves cellular 
phospholipids and generates second messenger mole- 
cules [l-5]. Two major classes of signal transduction 
enzymes, phospholipase A, and C, have received much 
more attention. Phospholipase A, forms lysophosphol- 
ipids and releases arachidonic acid leading to the pro- 
duction of platelet activated factor, prostaglandins, leu- 
kotrienes and other eicosanoides that are involved in a 
variety of pathophysiological events [5]. Phospholipase 
C hydrolyzes phosphatidylinositol4,5-bisphosphate to 
produce inositol- 1,4,5-trisphosphate and diacylglycerol 
(DG), which mobilize intracellular calcium and activate 
protein kinase C [1,3]. Phospholipase D (PLD) cata- 
lyzes the hydrolysis of phospholipids to form PA for 
which a role in signal transduction has not been conclu- 
sively established. However, several investigators have 
reported dephosphorylation of PA by PA phosphatase 
to yield DG [6-S] and the exposure of cells to PA can 
elicit several biological responses [9] which suggest a 
possible second messenger role in cellular responses. 
In the previous studies, we have demonstrated the 
degradation of PC in REF52 cells stimulated by VP or 
TPA [lo-121, but the metabolic pathway was not fully 
elucidated. The purpose of the present studies was to 
compare PLD activation by either hormone (VP) or 
tumor promotor (TPA) and to assess the role of Ca2’ 
and protein kinase C in response to the two dissimilar 
stimuli. 
2. MATERIALS AND METHODS 
2.1. Materials 
Correspondence address: C. Huang, Department of Biochemistry, 
Bowman Gray School of Medicine, Wake Forest University, Medical 
Center Boulevard, Winston-Salem, NC 27157-1016. USA. Fax: (1) 
(919) 716-7671. 
Abbreviations: REF52, rat embryo fibroblasts; TPA, 12-O-tetrade- 
canoylphorbol-13-acetate; VP, vasopressin; PEt, phosphatidyletha- 
nol; PA, phosphatidic acid: PLD, phospholipase D; PC, phosphati- 
dylcholine; PI, phosphatidylinositol; DG, diacylglycerol. In naming of 
PC, PI, PA, PEt and DG, we do not distinguish between the type of 
aliphatic linkage to glycerol (ester, ether). 
[2-3H]Glycerol (15 Ci/mmol) was a product of American Radiola- 
beled Chemicals (St. Louis, MO); [l-14C]myristic acid (58 mCi/mmol) 
was purchased from Du Pant/New England Nuclear. Powdered cul- 
ture media were obtained from Gibco (Gaithersburg, MD). Bovine 
serum albumin and [Arg’]VP (acetate salt) were purchased from 
Sigma. TPA was a product of Chemicals for Cancer Research (Eden 
Prairie, MN). Fetal bovine serum was supplied by HyClone (Logan, 
UT). Commercial phospholipids were from Avanti Polar Lipids, and 
neutral lipids were from Nu Chek Prep. Silica gel thin layer chroma- 
tography plates were a product of Analtech. Solvents were purchased 
from Fisher Scientific. Staurosporine was kmdly provided by Dr. 
Hiroshi Kase (Kyowa Kogyo Co., Ltd., Tokyo Research Laborato- 
ries, Tokyo). 
2.2. Culture, radmlabeling, and treatments of REF52 cells 
REF52 cells were obtained and cultured as previously described 
[1 I]. Stock cultures were maintained m 75-mm flasks and subcultured 
into 6-well plates or 35-mm dishes for experiments. REF52 cells were 
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Table I 
The formation of DG and PA and the degradation of phospholipids m REF52 cells by VP- or TPA-stimulation 
Lipid ‘H (dpm/dish) lJC (dpm/dish) 
Control VP TPA Control VP TPA 
DG 1,003 f 37 2,077 k 87 1,222 f 123 3,214 + 152 11,750 + 86 8.120 * 90 
PA 1,851 f 202 5,472 + 316 3,895 + 165 4.037 f 163 11,234 + 327 11,118 + 789 
PC 58,086 f. 3,375 58,569 f 6,008 58,986 f 1,535 408.024 k 5,190 385,380 f 26.049 373,865 + 3.672 
PE* 40,582 ?r 1,375 39,489 + 1,909 41,603 5 1,587 35.489 + 1.144 32.331 2 1,331 38.758 f 2.850 
PI + PS 30,249 ?I 2,804 25.891 + 1,540 33,100 + 1,222 15.702 f 1,655 13,106 f 1,421 14.808 f 1,016 
PI 17.838 + 977 11.359 f 758 17,238 f 1,616 14.780 f I.402 14,718 k 1.394 13.764 k 1,879 
REF52 cells were prelabeled with [ZH]glycerol (4.9 pCi/ml) and [“Clmyrtstic acid (0.5 ,&t/ml) and treated wrth 100 ng/ml VP or 80 nM TPA for 
10 min. Cellular lipids were extracted, resolved and quantttated as described in section 2. Data represent the mean of four determinattons. *PE. 
phosphatidylethanolamine; PS, phosphattdylserine. 
used at passage 8-15. Cultures were incubated with [‘HIglycerol and 
[“Clmyristic acid for 24 h in 5% fetal bovine serum medium beginning 
one day before confluency. After removal of the radiolabeling me- 
dium, cells were rinsed twice with serum- and isotope-free medium 
contammg 1 mg bovine serum albumin/ml, and equilibrated m the 
same medium for another 2 h. For the experiments, the cells were 
treated as described m the figure legends and tables. Total cellular 
lipids were extracted by the Bligh and Dyer procedure [I 31. modified 
to contain 1% HCl in methanol. 
2.3. Cellular lipid analysis 
Radtolabeled PA, DG. PEt, PC, PI, PI plus phosphatidylserme, and 
phosphatidylethanolamme were resolved by thm layer chromatogra- 
phy as prevtously described [8,1 I]. The radioactivity was quantitated 
by hqmd scintillation spectrometry. 
3. RESULTS 
3.1. The degradation of phospholipid by either VP- or 
TPA-stimulation 
The experiments presented here were designed to 
compare PLD activity induced by agonists of dissimilar 
nature: VP and TPA. We employed [3H]glycerol and 
[‘4C]myristic acid to selectively label the different 
phospholipids in REF52 cells. The data in Table I show 
that either VP or TPA induced a marked formation of 
radiolabeled PA and DG. VP treatment elicited 3.0-fold 
increases in [3H]PA and [14C]PA and concomitant in- 
creases in [‘H]DG (2. l-fold) and [14C]DG (3.6-fold), re- 
spectively. The incubation of REF52 cells with TPA 
resulted in increases in [3H]PA (2.1-fold) and [“C]PA 
(2.8-fold) and accompanying increases in [‘H]DG (1.2- 
fold) and [‘“C]DG (2.5-fold). One of the most important 
differences was that the formation of radiolabeled PA 
and DG was paralleled by the degradation of radiola- 
beled PC and PI in VP-induced cells, but by the degra- 
dation of radiolabeled PC only in TPA-induced cells. 
No significant changes were observed in the breakdown 
of phosphatidylethanolamine and phosphatidylserine 
of the same samples (Table I). 
3.2. The effect of staurosporine on VP- or TPA-induced 
PLD activity> 
We further detected the activity of PLD by determin- 
ing the formation of PEt in double labeled REF52 cells 
stimulated by VP or TPA in the presence of 2% ethanol. 
Table 11 
The hydrolysis of PC and PI in REF52 cells by VP- or TPA-stimulation m the presence or absence of staurosporine 
Cellular treatment PC (dpm/well ) PI (dpm/well) 
‘H ‘Y? ‘H 14C 
Control 57,744 f 3.050 408,017 + 12,956 17,733 + 823 14,989 + 195 
E 57,407 + 4,159 407,739 f 9,412 18,292 t 524 15,124 + 325 
VP+E 55,323 + 2,190 390,558 f. 7,530 14,514 f 673 10,052 f 849 
VP+E+St 58,306 ?I 1,821 410,901 f 6,680 16.761 + 733 12.506 f 837 
TPA + E 55,885 + 2.511 397.985 f 3,862 17,721 k 521 14,165 k 650 
TPA+E+St 57.786 + 3,065 410,487 f 4,358 17,771 + 844 14,926 2 691 
REF52 cells were double-labeled by Incubation with [‘HIglycerol (6.6 pCi/ml) and [“‘Clmyristic acid (0.5 @X/ml). Cells were treated with 100 &ml 
VP or 80 nM TPA medium containing 2% ethanol (E) m the presence or absence of 5 flM staurosporine (St) for 10 min. PC and PI were resolved 
and quantitated as described in section 2. The data are the average values from four determmattons. 
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Fig. I. The formation of i3H]PEt and [“‘C]PEt m REFS2 cells by VP- 
or TPA-Induced in the presence or absence of staurosporine. REF52 
cells were double-labeled by incubation with [‘HIglycerol (6.6 ,Ki/ml) 
and [‘4C]myristic acid (0.5 flCi/ml). Cells were treated with 100 &ml 
VP or 80 nM TPA medium containing 2% ethanol (E) in the presence 
or absence of 5 PM staurosporine (St) for 10 min. Cellular lipids were 
extracted, and radiolabeled PEt was resolved and quantitated as de- 
scribed in section 2. The data are the average values from four deter- 
minations. Control: ‘H, 2,542 k 314 dp~dish, and 14C, 3,652 + 320 
dpmfdrsh. 
Upon 10 min stimulation, VP initiated 2.3- and 3.0-fold 
increases in [3H]PEt and [14C]PEt, and TPA caused 1.4- 
and 2.3-fold increases in t3H]PEt and [14C]PEt respec- 
tively (Fig. 1). Measuring the concomitant conversion 
of PC and PI in the transphosphatidylation reaction 
showed that PC and PI were decreased upon VP-stimu- 
lation, but only PC upon TPA-stimulation (Table II). 
When 5 .uM staurosporine was added to the agonist- 
containing medium for 10 min, PLD activity was inhib- 
ited differentially depending upon the agonist used. The 
weak response to VP-treatment with staurosporine di- 
minished the formation of [3H]PEt and [‘4C]PEt by 27% 
and 53% (Fig. IA), whereas in the strong response to 
TPA-treatment. it inhibited the formation of [3H]PEt 
and [14C]PEt by 100% and 75% (Fig. 1B). These data 
suggest hat PLD activity can be regulated by a protein 
kinase C-dependent pathway in either VP- or TPA-stim- 
mated REF52 cells, however, activation of PLD by VP 
is, in part, brought about by a protein kinase C-inde- 
pendent mechanism. 
3.3. The effect of Ca” on VP- or TPA-induced PLD 
activity 
In order to more clearly compare the metabolic path- 
ways involved in the hydrolysis of phospholipids, exper- 
iments were designed to investigate the Ca2’-require- 
ment of PLD activity in VP- or TPA-induced REFSZ 
cells. Incubations were performed in medium contain- 
ing 2% ethanol and either VP or TPA in the presence 
or absence of 1 mM EGTA for 10 min. The inclusion 
of EGTA decreased the formation of [3H]PEt and 
[14C]PEt o 31% and 17% of the VP-induced response 
(Fig. 2A), respectively. In contrast, the formation of 
radiolabeled-PEt by TPA-stimulation was similar in the 
presence or absence of EGTA (Fig. 2B). 
4. DISCUSSION 
Several groups have demonstrated a PLD pathway 
for PC degradation in agonist-stimulated cells [6-&l& 
171. Studies of PC metabolism in intact cells were facil- 
itated by employing radiolabeled myristic acid [10,14]. 
However, prelabeling with glycerol resulted in much 
higher incorporation of the radioIabeled precursor into 
the cellular PI fraction (Table I) [8,17]. Using this dou- 
ble-labeling approach helps to trace the metabolism of 
different phospholipids in the same system. The results 
reported herein indicate that PLD acts on PC in REF52 
cells treated with VP and TPA. Meanwhile, we found 
that the accumulation of double-labeled PA or PEt by 
VP-activated PLD was partially associated with the hy- 
drolysis of PI, in contrast, TPA completely failed to 
induce PI degradation (Tables I and II). On the other 
hand, we have recently observed that VP induces pol- 
yphosphoinositides and PC degradation in REF52 cells 
[lo-121. With regard to phorbol ester-induced turnover 
of phosphoinositides, several investigators have indi- 
cated these agents do not stimulate the hydrolysis of 
polyphosphoinositides [ 18,191. Taken together. the re- 
sults suggest hat the difference of phospholipid degra- 
dation in response to VP and TPA may be relevant to 
extracellular signals of hormone and tumor promotors, 
and that the dual pathways elicited by VP imply a 
hormone self-adjusted function in lipid metabolism and 
cell responses. 
The mechanism of PLD activation by agonists has 
been attributed to various mechanisms. PLD activation 
by TPA-stimulation is thought to be mediated by a 
protein kinase C-dependent pathway [3,6,10,14-161. 
3H 14c 3H 14c 
Fig. 2. The formation of [‘HIPEt and [W]PEt in REF52 cells by VP- 
or TPA-induced in the presence or absence of EGTA. REFSZ cells 
were double-ladle by incubation with [3H]g~y~roI (7.2 @i/ml) and 
[“‘C]myristic acid (0.8 &Xml) and treated with 100 r&ml VP or 80 
nM TPA medium containmg 2% ethanol (E) in the presence or ab- 
sence of 1 mM EGTA for 10 min. Cellular lipids were extracted, and 
radiolabeled PEt was resolved and quantitated as described in sectton 
2. The results represent he mean of triplicate, and two experiments 
yielded similar results. Control: ‘H. 3,432 t 484 dpmldtsh, and “‘C. 
5.253 2 177 dpmidish. 
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However, experiments have been carried out in hepato- 
cytes indicating that VP-induced PC hydrolysis by PLD 
is G-protein coupled [20]. Our previous results indicate 
that VP-elicited PC degradation by PLD is in part reg- 
ulated by protein kinase C [I I], TPA-induced PEt for- 
mation is independent of extracellular calcium in several 
cell lines [8]. Using staurosporine and EGTA, the cur- 
rent report has demonstrated that VP induces the con- 
current dual PLD activities that are protein kinase C- 
and Ca’+-dependent. In contrast, TPA activates a pro- 
tein kinase C-dependent PLD activity only, and not the 
Ca”-dependent activity (Figs. 1 and 2). Reinhold et al. 
[21] reported that there are three separable mechanisms 
to activate PLD in human neutrophils. The phenome- 
non of agonist-selective activation provides an interest- 
ing clue into the physiological role of PLD in signal 
transduction. 
The above data implicating multiple PLD-mediated 
pathways were based on: (i) the concomitant degrada- 
tion of various phospholipids in the formation of PA 
and PEt; (ii) the inhibition of PLD in response to some 
agonists by staurosporine; and (iii) the degree of Ca’+- 
requirement in PLD action. Although the recent reports 
demonstrated a PI-PLD and a PC-PLD in Madin 
Darby canine kidney cells [18] and a PLD hydrolyzing 
phosphatidylethanolamine in NIH 3T3 fibroblasts [22], 
the dual PLD activities which require protein kinase C 
and Cal+, and hydrolyze PC and PI in REF52 cells 
provide a system to explore the complicated relation- 
ship between metabolic pathways and multiforms of PLD. 
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